Recruiting Obesity Studies in Saint Paul
A Trial of Setmelanotide in Patients With Congenital Hypothalamic Obesity (Sub-study of NCT05774756)
This is a sub-study of Study RM-493-040 (NCT05774756). The goal of this sub-study is to learn how well Setmelanotide works to improve weight reduction, hunger, and quality of life in patients 4 years...
Tirzepatide in PWS, HO and GNSO
This research study is comparing the effectiveness of a weight loss medication called Tirzepatide in young adults with Prader-Willi Syndrome and/or hypothalamic obesity, as compared to young adults wi...
About Obesity Clinical Trials in Saint Paul
Obesity is a complex chronic disease involving an excessive amount of body fat that increases the risk of other diseases and health problems. It affects over 650 million adults worldwide. Treatment approaches include lifestyle modifications, medications (GLP-1 agonists), and bariatric surgery.
There are currently 2 obesity clinical trials recruiting participants in Saint Paul, MN. These studies are seeking a combined 75 participants. Research is being sponsored by Rhythm Pharmaceuticals, Inc., Grace Kim. Clinical trial participation is free and participants receive study-related medical care at no cost.
Obesity Clinical Trials in Saint Paul — FAQ
Are there obesity clinical trials in Saint Paul?
Yes, there are 2 obesity clinical trials currently recruiting in Saint Paul, MN. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Saint Paul?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Saint Paul research site will contact you about next steps.
Are clinical trials in Saint Paul free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Saint Paul studies also compensate for your time and travel.
What obesity treatments are being tested?
The 2 active trials in Saint Paul are testing new therapies including novel drugs, biologics, and treatment approaches for obesity.
Data updated March 2, 2026 from ClinicalTrials.gov